News & events
NuChem Sciences announces new Discovery Partner Program™
April 15, 2021
This new service offers our team’s superior talent and our cutting-edge scientific technology, paired with responsive communication, efficiency and clarity along the drug discovery journey.
NuChem Sciences launches new brand and announces new name
April 15, 2021
After experiencing exponential growth in recent years, NuChem Therapeutics is proud to launch its new brand identity. As part of this exciting step forward, we will adopt a new corporate name: NuChem Sciences.
Universite de Montreal Journee Carriere
January 15, 2020
Our team was happy to meet and greet students at the Universite de Montreal MIL Campus as part of the Journee Carriere event.
NuChem Therapeutics Completed the Acquisition of Amplia Pharmatek
October 19, 2019
Amplia Pharmatek is an innovative service provider who specializes in Discovery Biology, in vivo Pharmacology, Pharmacokinetics and Toxicology.
Completion of a Successful Management Buyout Transaction At NuChem Therapeutics
February 22, 2019
On December 13th 2018, senior management of the company, comprised of Marc LeBel, Daniel Guay, Marc Janes and John Mancuso, acquired 95% of the voting shares from Amorchem LP, the venture capital fund which founded NuChem in 2011.
Transform Ideas Through Science
A drug discovery and chemical development contract research organization.
NuChem Sciences Inc.
2350 Rue Cohen Suite 201
Canada H4R 2N6
514 416 5659